Spexis to host business update conference call on October 9, 2023
October 06, 2023 01:30 ET
|
Spexis AG
Spexis to host business update conference call on October 9, 2023
Spexis provides business update and announces financial results for the first half of 2023
September 29, 2023 01:30 ET
|
Spexis AG
Spexis provides business update and announces financial results for the first half of 2023
Cystic Fibrosis Market to Surpass USD 39.59 Billion by 2030 Driven by Growing Patient Population and Supportive Government Initiatives | Research by SNS Insider
September 20, 2023 09:48 ET
|
SNS Insider pvt ltd
Pune, Sept. 20, 2023 (GLOBE NEWSWIRE) -- “The SNS Insider report indicates that in 2022, the Cystic Fibrosis Market was valued at USD 7.13 billion in 2022 & is projected to reach USD 39.59...
Vibrating Mesh Nebulizer Market Predicted to Reach USD 719.2 million by 2031, Expanding at a CAGR of 9.2%: TMR Report
September 15, 2023 08:04 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global vibrating mesh nebulizer market is projected to flourish at a CAGR of 9.2% from...
First Wave BioPharma to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
September 05, 2023 07:00 ET
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., Sept. 05, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
Ultrasonic Nebulizers Market to Exceed USD 325.6 million by 2031, Expanding at a CAGR of 5.4% | Exclusive Report by Transparency Market Research
August 21, 2023 05:53 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global ultrasonic nebulizers market is projected to flourish at a CAGR of 5.4% from...
Spexis announces USD $2.5 million capital commitment to support the upcoming Phase 3 ColiFin® studies
August 15, 2023 01:15 ET
|
Spexis AG
Ad hoc announcement pursuant to Art. 53 LR ALLSCHWIL, Switzerland, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on macrocycle...
Claire’s Place Foundation Launches First East Coast Glow Ride for Cystic Fibrosis
August 08, 2023 11:50 ET
|
Claire's Place Foundation
Los Angeles, CA, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Claire’s Place Foundation, a non-profit organization providing support to children and families affected by cystic fibrosis (CF), is excited to...
Claire’s Place Foundation Announces 9th Annual Glow Ride for Cystic Fibrosis
July 13, 2023 08:00 ET
|
Claire's Place Foundation
Los Angeles, CA, July 13, 2023 (GLOBE NEWSWIRE) -- Claire’s Place Foundation, a non-profit organization providing support to children and families affected by cystic fibrosis (CF), is proud to...
First Wave BioPharma Announces Initial Topline Results from Phase 2 SPAN Clinical Trial Investigating Enhanced Adrulipase Formulation
July 13, 2023 07:00 ET
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., July 13, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...